Conventional radiography and correlated factors of enthesopathies of the Achilles tendon and plantar fascia in patients with axial spondyloarthritis

Ebru Yılmaz; Özge Pasin; Loiane Cristina de Souza; Guilherme Torres Vilarino; Alexandro Andrade; Camila Gusmão Vicente de Carvalho; Barbara Bayeh; Fernando Henrique Carlos de Souza; Renata Miossi; Pleiades Tiharu Inaoka; Takashi Matsushita; Naoki Mugii; Samuel Katsuyuki Shinjo

doi:10.4081/reumatismo.2024.1709

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Psoriatic arthritis: treatment strategies using biologic agents

S. D'Angelo, C. Palazzi, I. Olivieri

113-121

05-06-2012

https://doi.org/10.4081/reumatismo.2012.113

1324

PDF: 1188
Psoriatic arthritis. When the heterogeneity requires normality

L. Punzi, R. Ramonda

59-65

05-06-2012

https://doi.org/10.4081/reumatismo.2012.59

904

PDF: 731
Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter?

J. Mencarini, M. Spinicci, F. Bartalesi

144-147

16-12-2016

https://doi.org/10.4081/reumatismo.2016.897

2014

PDF: 1161
BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS

D.D. Gladman

85-87

https://doi.org/10.4081/reumatismo.2007.1s.85

652

PDF: 585
Effects of TNF antagonists on immune and neuroendocrine system

G. Valesini, M. Cutolo

3-7

https://doi.org/10.4081/reumatismo.2005.4s.3

1213

PDF: 795
IMMUNOPATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS AND PHARMACOLOGICAL PERSPECTIVES

S. Loffredo, F. Ayala, G.C. Marone, A. Genovese, G. Marone

28-39

https://doi.org/10.4081/reumatismo.2007.1s.28

991

PDF: 832
MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco

132-139

https://doi.org/10.4081/reumatismo.2009.132

1949

PDF: 1152
Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis

I. Olivieri, Salvatore D'Angelo, C. Palazzi, P. Leccese, A. Nigro, A. Padula

1-3

28-03-2013

https://doi.org/10.4081/reumatismo.2013.1

2314

PDF: 758
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

173-177

19-11-2020

https://doi.org/10.4081/reumatismo.2020.1289

1709

PDF: 1028
Side effects of anti-TNFa therapy in juvenile idiopathic arthritis

Irene Pontikaki, Valeria Gerloni, Maurizio Gattinara, Alfredomaria Lurati, Alessandra Salmaso, Gabriele De Marco, Barbara Teruzzi, Elisabetta Valcamonica, Flavio Fantini

31-38

https://doi.org/10.4081/reumatismo.2006.31

1816

PDF: 2572
Approved indications and other possible utilizations of anti-TNFa biologic drugs

W. Grassi, C. Montecucco

30-33

https://doi.org/10.4081/reumatismo.2005.4s.30

1172

PDF: 899
Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study

F.M. Perrotta, A. Delle Sedie, S. Scriffignano, P. Volpe, E. Cordisco, N. Milano, M. Gabini, E. Lubrano

52-59

10-04-2020

https://doi.org/10.4081/reumatismo.2020.1266

2065

PDF: 1189
Coexisting rheumatoid arthritis and sickle cell disease: case series and literature review

Abdallah Alqethami, Sabri Alsaeedi, Samera Felemban, Abdulelah Qadi

07-01-2025

https://doi.org/10.4081/reumatismo.2025.1682

1795

PDF: 163
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis

L. Quartuccio, S. Salvin, M. Saracco, S. Lombardi, M. Fabris, E. Mansutti, M. Maset, S. Pellerito, S. De Vita

182-186

https://doi.org/10.4081/reumatismo.2009.182

1034

PDF: 743

1 - 14 of 14 items

Search

Search Results

Psoriatic arthritis: treatment strategies using biologic agents

Psoriatic arthritis. When the heterogeneity requires normality

Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter?

BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS

Effects of TNF antagonists on immune and neuroendocrine system

IMMUNOPATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS AND PHARMACOLOGICAL PERSPECTIVES

MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis

COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

Side effects of anti-TNFa therapy in juvenile idiopathic arthritis

Approved indications and other possible utilizations of anti-TNFa biologic drugs

Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study

Coexisting rheumatoid arthritis and sickle cell disease: case series and literature review

Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis

authors

reviewers

Categories

indexing

Keywords